Neuroblastoma Treatment Market

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child.
Neuroblastoma Treatment Market aims to provide a comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroblastoma Treatment. Neuroblastoma Treatment Market contains market size and forecasts of Neuroblastoma Treatment in global, including the following market information:
Global Neuroblastoma Treatment Market Revenue, 2018-2023, 20242035, ($ millions)
Global top five companies in 2022 (%)
The global Neuroblastoma Treatment market was valued at US$ 456.9 million in 2022 and is projected to reach US$ 575.4 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Combination Chemotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neuroblastoma Treatment include Seattle Children?s, CureSearch, Texas Children?s, NANT, Sino Biopharmaceutical, Jiangsu Hengrui Medicine Co.,Ltd., Fosun Pharmaceutical, Novartis and Juno Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neuroblastoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuroblastoma Treatment Market, by Type, 2018-2023, 20242035 ($ millions)
Global Neuroblastoma Treatment Market Segment Percentages, by Type, 2022 (%)
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Global Neuroblastoma Treatment Market, by Application, 2018-2023, 20242035 ($ millions)
Global Neuroblastoma Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Neuroblastoma Treatment Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Neuroblastoma Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuroblastoma Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neuroblastoma Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Seattle Children?s
CureSearch
Texas Children?s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neuroblastoma Treatment, market overview.
Chapter 2: Global Neuroblastoma Treatment market size in revenue.
Chapter 3: Detailed analysis of Neuroblastoma Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neuroblastoma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.